# Intracardiac Flow Assessment in Cardiac Amyloidosis

> **NCT05379101** · — · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 100 (estimated)

## Conditions studied

- Amyloidosis Cardiac
- Healthy Adults

## Interventions

- **DIAGNOSTIC_TEST:** Cardiac magnetic resonance image (CMR)
- **DIAGNOSTIC_TEST:** Transthoracic Echocardiogram (TTE)
- **DIAGNOSTIC_TEST:** Six-minute Walk Test

## Key facts

- **NCT ID:** NCT05379101
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-20
- **Primary completion:** 2026-05
- **Final completion:** 2026-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05379101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05379101, "Intracardiac Flow Assessment in Cardiac Amyloidosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05379101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*